Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 758682, 7 pages
http://dx.doi.org/10.1155/2013/758682
Review Article

The Role of Red Blood Cells in Enhancing or Preventing HIV Infection and Other Diseases

1University of Botswana, Department of Medical Laboratory Sciences, Faculty of Health Sciences, Gaborone, Botswana
2Oxidative Stress Research Centre, Department of Biomedical Sciences, Faculty of Health & Wellness Sciences, Cape Peninsula University of Technology, Bellville 7535, South Africa

Received 3 June 2013; Accepted 13 September 2013

Academic Editor: Esteban Martinez

Copyright © 2013 Modisa S. Motswaledi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Bowman, “Hemolytic disease of the newborn,” Vox Sanguinis, vol. 70, pp. 62–67, 1996. View at Google Scholar · View at Scopus
  2. S. J. Neil, S. Magre, A. McKnight, and R. A. Weiss, “A-B-O blood groups and HIV-1 infection,” Antiviral Therapy, vol. 8, abstract 134, 2003. View at Google Scholar
  3. D. J. Anstee, “The relationship between blood groups and disease,” Blood, vol. 115, no. 23, pp. 4635–4643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Le Pendu, N. Ruvoën-Clouet, E. Kindberg, and L. Svensson, “Mendelian resistance to human norovirus infections,” Seminars in Immunology, vol. 18, no. 6, pp. 375–386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. K. Sayal, A. L. Das, and S. K. Nema, “Study of blood groups in HIV seropositive patients,” Indian Journal of Dermatology, Venereology and Leprology, vol. 62, pp. 295–297, 1996. View at Google Scholar
  6. M. Arendrup, J. E. S. Hansen, H. Clausen, C. Nielsen, L. R. Mathiesen, and J. O. Nielsen, “Antibody to histo-blood group A antigen neutralizes HIV produced by lymphocytes from blood group A donors but not from blood group B or O donors,” AIDS, vol. 5, no. 4, pp. 441–444, 1991. View at Google Scholar · View at Scopus
  7. A. A. Abdulazeez, E. B. Alo, and S. N. Rebecca, “Carriage rate of human immunodeficiency virus (HIV) infection among different ABO and Rhesus blood groups in Adamawa state, Nigeria,” Biomedical Research, vol. 19, no. 1, pp. 41–44, 2008. View at Google Scholar · View at Scopus
  8. J. O. Dirisu, T. O. Alli, A. O. Adegoke, and F. Osazuwa, “A survey of prevalence of serum antibodies to human immunodeficiency deficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) among blood donors,” North American Journal of Medical Sciences, vol. 3, no. 1, pp. 35–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Bolton and R. F. Garry, “Sequence similarity between the erythrocyte binding domain of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals a functional heparin binding motif involved in binding to the Duffy antigen receptor for chemokines,” Virology Journal, vol. 8, p. 523, 2011. View at Google Scholar · View at Scopus
  10. A. Lachgar, G. Jaureguiberry, H. Le Buenac et al., “Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC),” Biomedicine and Pharmacotherapy, vol. 52, no. 10, pp. 436–439, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Ramsuran, H. Kulkarni, W. He et al., “Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women,” Clinical Infectious Diseases, vol. 52, no. 10, pp. 1248–1256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. W. He, S. Neil, H. Kulkarni et al., “Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility,” Cell Host and Microbe, vol. 4, no. 1, pp. 52–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Lund, M. L. Olsson, S. Ramkumar et al., “The human Pk histo-blood group antigen provides protection against HIV-1 infection,” Blood, vol. 113, no. 20, pp. 4980–4991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. E. O. Ukaejiofo and T. Nubila, “Association between ABO, Rhesus blood group systems and haemoglobin genotype among confirmed HIVAIDS-TB co-infected patients in Enugu Urban, Nigeria,” West African Journal of Medicine, vol. 25, no. 1, pp. 61–64, 2006. View at Google Scholar · View at Scopus
  15. C. A. Winkler, P. An, R. Johnson, G. W. Nelson, and G. Kirk, “Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans,” Cell Host and Microbe, vol. 5, no. 5, pp. 411–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Beck, B. K. Brown, L. Wieczorek et al., “Human erythrocytes selectively bind and enrich infectious HIV-1 virions,” PLoS ONE, vol. 4, no. 12, Article ID e8297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Puri, P. Hug, I. Muñoz-Barroso, and R. Blumenthal, “Human erythrocyte glycolipids promote HIV-1 envelope glycoprotein-mediated fusion of CD4+ cells,” Biochemical and Biophysical Research Communications, vol. 242, no. 1, pp. 219–225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Hammache, N. Yahi, M. Maresca, G. Piéroni, and J. Fantini, “Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3),” Journal of Virology, vol. 73, no. 6, pp. 5244–5248, 1999. View at Google Scholar · View at Scopus
  19. P. Greenwell, “Blood group antigens: molecules seeking a function?” Glycoconjugate Journal, vol. 14, no. 2, pp. 159–173, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Mudad and M. J. Telen, “Biologic functions of blood group antigens,” Current Opinion in Hematology, vol. 3, no. 6, pp. 473–479, 1996. View at Google Scholar · View at Scopus
  21. M. J. Telen, “Erythrocyte blood group antigens: not so simple after all,” Blood, vol. 85, no. 2, pp. 299–306, 1995. View at Google Scholar · View at Scopus
  22. G. Daniels, “Functional aspects of red cell antigens,” Blood Reviews, vol. 13, no. 1, pp. 14–35, 1999. View at Google Scholar · View at Scopus
  23. T. J. Hadley and S. C. Peiper, “From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen,” Blood, vol. 89, no. 9, pp. 3077–3091, 1997. View at Google Scholar · View at Scopus
  24. R. Nibbs, G. Graham, and A. Rot, “Chemokines on the move: control by the chemokine “interceptors” Duffy blood group antigen and D6,” Seminars in Immunology, vol. 15, no. 5, pp. 287–294, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Gardner, A. M. Patterson, B. A. Ashton, M. A. Stone, and J. Middleton, “The human Duffy antigen binds selected inflammatory but not homeostatic chemokines,” Biochemical and Biophysical Research Communications, vol. 321, no. 2, pp. 306–312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. J. Telen, K. B. Roberts, and J. A. Bartlett, “HIV-associated autoimmune hemolytic anemia: report of a case and review of the literature,” Journal of Acquired Immune Deficiency Syndromes, vol. 3, no. 10, pp. 933–937, 1990. View at Google Scholar · View at Scopus
  27. D. Reich, M. A. Nalls, W. H. L. Kao et al., “Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene,” PLoS Genetics, vol. 5, no. 1, Article ID e1000360, 2009. View at Publisher · View at Google Scholar
  28. J.-P. Cartron, “Blood groups: genetics and physiology,” ISBT Science Series, vol. 5, no. 1, pp. 27–45, 2010. View at Publisher · View at Google Scholar
  29. E. Horakova, O. Gasser, S. Sadallah et al., “Complement mediates the binding of HIV to erythrocytes,” The Journal of Immunology, vol. 173, no. 6, pp. 4236–4241, 2004. View at Google Scholar · View at Scopus
  30. T. C. Dawson, A. B. Lentsch, Z. Wang et al., “Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC),” Blood, vol. 96, no. 5, pp. 1681–1684, 2000. View at Google Scholar · View at Scopus
  31. H. Wazirali, R. A. Ashfaque, and J. W. Herzig, “Association of blood group A with increased risk of coronary heart disease in the Pakistani population,” Pakistan Journal of Physiology, vol. 1, no. 1-2, 2005. View at Google Scholar
  32. P. Clark and O. Wu, “ABO blood groups and thrombosis: a causal association, but is there value in screening?” Future Cardiology, vol. 7, no. 2, pp. 191–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Schleef, E. Strobel, A. Dick, J. Frank, W. Schramm, and M. Spannagl, “Relationship between ABO and secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals,” British Journal of Haematology, vol. 128, no. 1, pp. 100–107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Lourenço, F. Miranda, and L. H. C. Lopes, “ABO blood groups as risk factors for thrombosis,” Clinical and Applied Thrombosis/Hemostasis, vol. 2, no. 3, pp. 196–199, 1996. View at Publisher · View at Google Scholar
  35. P. V. Jenkins and J. S. O'Donnell, “ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?” Transfusion, vol. 46, no. 10, pp. 1836–1844, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Engelmann, U. Schumacher, and E. Haen, “Epidermal growth factor binding sites on human erythrocytes in donors with different ABO blood groups,” American Journal of Hematology, vol. 39, no. 4, pp. 239–241, 1992. View at Google Scholar · View at Scopus
  37. V. Ravn, C. Stubbe Teglbjaerg, U. Mandel, and E. Dabelsteen, “The distribution of type-2 chain histo-blood group antigens in normal cycling human endometrium,” Cell and Tissue Research, vol. 270, no. 3, pp. 425–433, 1992. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Ravn, U. Mandel, B. Svenstrup, and E. Dabelsteen, “N-acetyllactosamine and sialosyl-N-acetyllactosamine in normal and malignant human endometrium,” Glycosylation & Disease, vol. 1, no. 4, pp. 271–278, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. J. W. Barnwell, M. E. Nichols, and P. Rubinstein, “In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax,” Journal of Experimental Medicine, vol. 169, no. 5, pp. 1795–1802, 1989. View at Google Scholar · View at Scopus
  40. C. Hess, T. Klimkait, L. Schlapbach et al., “Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study,” The Lancet, vol. 359, no. 9325, pp. 2230–2234, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. R. O. Nneli, B. O. Ekpo, J. Egene, and O. C. Ohaeri, “Prevalence of Rh and ABO blood groups in HIV seroposititve pregnant women in Enugu, Nigeria,” Nigerian Journal of Physiological Sciences, vol. 19, pp. 7–9, 2004. View at Google Scholar
  42. R. A. Rachkewich, M. C. Crookston, C. A. Tilley, and J. R. Wherrett, “Evidence that blood group A antigen on lymphocytes is derived from the plasma,” Journal of Immunogenetics, vol. 5, no. 1, pp. 25–29, 1978. View at Google Scholar · View at Scopus
  43. K. C. Horne, X. Li, L. P. Jacobson et al., “Duffy antigen polymorphisms do not alter progression of HIV in African Americans in the MACS cohort,” Cell Host and Microbe, vol. 5, no. 5, pp. 415–417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. W. He, S. Neil, H. Kulkarni et al., “Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility,” Cell Host and Microbe, vol. 4, no. 1, pp. 52–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. C. A. Winkler, P. An, R. Johnson, G. W. Nelson, and G. Kirk, “Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans,” Cell Host and Microbe, vol. 5, no. 5, pp. 411–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Nilsson, G. E. Rydell, J. Le Pendu, and G. Larson, “Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids,” Glycoconjugate Journal, vol. 26, no. 9, pp. 1171–1180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Shirato-Horikoshi, S. Ogawa, T. Wakita, N. Takeda, and G. S. Hansman, “Binding activity of norovirus and sapovirus to histo-blood group antigens,” Archives of Virology, vol. 152, no. 3, pp. 457–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Tan and X. Jiang, “Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle,” Trends in Microbiology, vol. 13, no. 6, pp. 285–293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Mocroft, O. Kirk, S. E. Barton et al., “Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe,” AIDS, vol. 13, no. 8, pp. 943–950, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. R. J. Harris, J. A. C. Sterne, S. Abgrall et al., “Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies,” Antiviral Therapy, vol. 13, no. 8, pp. 959–967, 2008. View at Google Scholar · View at Scopus
  51. E. Olayemi, O. A. Awodu, and G. N. Bazuaye, “Autoimmune hemolytic anemia in HIV-infected patients: a hospital based study,” Annals of African Medicine, vol. 7, no. 2, pp. 72–76, 2008. View at Google Scholar · View at Scopus
  52. P. A. Volberding, K. R. Baker, and A. M. Levine, “Human immunodeficiency virus hematology,” Hematology, vol. 2003, pp. 294–313, 2003. View at Google Scholar · View at Scopus
  53. G. Weiss and L. T. Goodnough, “Anemia of chronic disease,” The New England Journal of Medicine, vol. 352, no. 10, pp. 1011–1023, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. Beck and C. R. Alving, “Interactions of infectious HIV-1 virions with erythrocytes: implications for HIV-1 pathogenesis and infectivity,” in HIV-Host Interactions, T. L. Chang, Ed., In-Tech, 2011. View at Google Scholar
  55. J. Martins-Silva, N. C. Santos, M. Doroana et al., “Changes in blood cell membrane properties in HIV type-1-infected patients,” AIDS Research and Human Retroviruses, vol. 22, no. 9, pp. 849–853, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Fantuzzi, F. Spadaro, C. Purificato et al., “Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages,” Blood, vol. 111, no. 7, pp. 3355–3363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Ramoni, F. Spadaro, M. Menegon, and F. Podo, “Cellular localization and functional role of phosphatidylcholine-specific phospholipase C in NK cells,” The Journal of Immunology, vol. 167, no. 5, pp. 2642–2650, 2001. View at Google Scholar · View at Scopus
  58. K. A. Johansen, R. E. Gill, and M. L. Vasil, “Biochemical and molecular analysis of phospholipase C and phospholipase D activity in mycobacteria,” Infection and Immunity, vol. 64, no. 8, pp. 3259–3266, 1996. View at Google Scholar · View at Scopus
  59. K. Côtes, J. C. Bakala N'goma, R. Dhouib et al., “Lipolytic enzymes in Mycobacterium tuberculosis,” Applied Microbiology and Biotechnology, vol. 78, no. 5, pp. 741–749, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. J. C. Bakala N'Goma, M. Schué, F. Carrière, A. Geerlof, and S. Canaan, “Evidence for the cytotoxic effects of Mycobacterium tuberculosis phospholipase C towards macrophages,” Biochimica et Biophysica Acta, vol. 1801, no. 12, pp. 1305–1313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Schué, D. Maurin, R. Dhouib et al., “Two cutinase-like proteins secreted by Mycobacterium tuberculosis show very different lipolytic activities reflecting their physiological function,” The FASEB Journal, vol. 24, no. 6, pp. 1893–1903, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Hütter, D. Nowak, M. Mossner et al., “Long-term control of HIV by CCR5 delta32/delta32 stem-cell transplantation,” The New England Journal of Medicine, vol. 360, no. 7, pp. 692–698, 2009. View at Publisher · View at Google Scholar · View at Scopus